Takeshi Shimamura’s primary research interest is in the area of understanding the mechanisms that drive acquired targeted-drug resistance with a mesenchymal phenotype in non-small cell lung carcinoma (NSCLC) and small-cell lung cancer (SCLC). The goal of his research is to develop therapeutic strategies to overcome the acquired and de novo targeted-drug resistance using both in vitro and in vivo models.

Takeshi Shimamura, PhD, MS
Associate Professor
Department of Surgery, Division of Cardiology
College of Medicine
Research Program
Cancer Biology (CB)
Phone: 312-355-0156
Email: tshima2@uic.edu